Agency Forms Undergoing Paperwork Reduction Act Review, 41267-41268 [2017-18407]

Download as PDF 41267 Federal Register / Vol. 82, No. 167 / Wednesday, August 30, 2017 / Notices questionnaires and provide samples for laboratory testing. Researchers will follow all studyparticipating mothers’ newborns every other week from birth to 6 months of age. At all visits, infants will receive national recommended clinical care (at birth and follow-up visits at 1, 2, and 6 months), provide samples for laboratory testing, and mothers will complete study-specific questionnaires about infant ZIKV symptoms and developmental milestones. During follow-up, infants will also have cranial performed to exam developmental delays. Researchers will use the study results use to guide recommendations made by both INS and CDC to prevent ZIKV infection; to improve counseling of patients about risks to themselves, their pregnancies, their partners, and their infants; and to help agencies prepare to provide services to affected children and families. Participation in this study is voluntary and there are no costs to participants other than their time. ultrasounds, their head circumference measured, and hearing and vision tests. For mothers and their infants, researchers will abstract relevant clinical care information from medical records. The revised information collection package includes the following changes. During the data collection period, researchers will follow a subset of 300 infants until 2-years of age. These infants will have answer questionnaires at 6, 12, 18, and 24 months, as well as have other clinical assessments ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden hours Respondents Form name Pregnant women ................... Pregnant women eligibility questionnaire .... Pregnant women enrollment questionnaire Adult symptoms questionnaire ..................... Pregnant women follow-up questionnaire .... Infant symptoms questionnaire .................... Ages and Stages Questionnaire: 2, 4, 6 Month. Ages and Stages Questionnaire: 12, 18, 24 Month. Center for Epidemiologic Studies Depression—10. Male partner eligibility questionnaire ........... Male enrollment questionnaire ..................... Adult symptoms questionnaire ..................... 3,125 2,500 2,500 2,500 2,250 2,250 300 300 1 1 15 8 14 2 3 3 5/60 35/60 10/60 15/60 10/60 15/60 15/60 5/60 260 1,458 6,250 5,000 5,250 1,125 225 75 2,500 625 625 1 1 7 5/60 25/60 10/60 208 260 729 ....................................................................... ........................ ........................ ........................ 20,840 Male partners ........................ Total ............................... Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017–18405 Filed 8–29–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–17–0004] mstockstill on DSK30JT082PROD with NOTICES Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. VerDate Sep<11>2014 17:40 Aug 29, 2017 Jkt 241001 Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project National Disease Surveillance Program II. Disease Summaries (OMB Control Number 0920–0004, Expires 10/31/2017)—Revision—National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC requests a three-year approval for the proposed revision of the ‘‘National Disease Surveillance Program II. Disease Summaries’’ information collection project. As with the previous approval, these data are essential for measuring trends in diseases, evaluating the effectiveness of current preventive strategies, and determining the need to modify current preventive measures. E:\FR\FM\30AUN1.SGM 30AUN1 41268 Federal Register / Vol. 82, No. 167 / Wednesday, August 30, 2017 / Notices Diseases included in this surveillance program are Influenza Virus, Caliciviruses, Respiratory and Enteric Viruses, Foodborne Outbreaks, Waterborne Outbreaks and Enteroviruses. Proposed revisions include form consolidation, minor revised language and rewording to improve clarity and readability of the data collection forms and the discontinuation of multiple previously approved influenza collection instruments, and the National Respiratory & Enteric Virus Surveillance System (NREVSS) Laboratory Assessment (CDC 55.83). CDC also requests the use of a new form, Suspect Respiratory Virus Patient Form, to assist health departments and clinical sites when they submit specimens to the CDC lab for viral pathogen identification. The data will enable rapid detection and characterization of outbreaks of known pathogens, as well as potential newly emerging viral pathogens. The frequency of response for each form will depend on the disease and surveillance need. This represents a 7,116 burden hour reduction since last approval. This reduction in burden hours is attributed primarily to the discontinuation of previously approved forms and formatting changes to existing forms. The total time burden estimate for all collection instruments in this revision request is 24,805. There are no costs to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Form name Epidemiologist ............ NORS Foodborne Disease Transmission_Person to Person Disease Transmission_Animal Contact_Environmental Contamination_Unknown Transmission Mode_52.13. WHO COLLABORATING CENTER FOR INFLUENZA Influenza Virus Surveillance. U.S. WHO Collaborating Laboratories Influenza Testing Methods Assessment. US Outpatient Influenza-like Illness Surveillance Network (ILINet) Weekly_CDC 55.20. US Outpatient Influenza-like Illness Surveillance Network (ILINet) Workfolder 55.20E. Influenza-Associated Pediatric Mortality Case Report Form .............. Human Infection with Novel Influenza A Virus Case Report Form .... Human Infection with Novel Influenza A Virus Severe Outcomes ..... Novel Influenza A Virus Case Screening Form .................................. Antiviral Resistant Influenza Infection Case Report Form .................. National Respiratory & Enteric Virus Surveillance System (NREVSS) (55.83A, B, D) (electronic). National Enterovirus Surveillance Report: (CDC 55.9) (electronic) .... National Adenovirus Type Reporting System (NATRS) ..................... Middle East Respiratory Syndrome (MERS) Patient Under Investigation (PUI) Short Form. Viral Gastroenteritis Outbreak Submission Form ................................ NORS Waterborne Disease Transmission Form_52.12 ..................... Influenza Virus (Electronic, Year Round), PHLIP_HL7 messaging Data Elements. Influenza virus (electronic, year round) (PHIN–MS) ........................... Suspect Respiratory Virus Patient Form ............................................. Epidemiologist ............ Epidemiologist ............ Epidemiologist ............ Epidemiologist ............ Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist ............ ............ ............ ............ ............ ............ Epidemiologist ............ Epidemiologist ............ Epidemiologist ............ Epidemiologist ............ Epidemiologist ............ Epidemiologist ............ Epidemiologist ............ Epidemiologist ............ Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017–18407 Filed 8–29–17; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier CMS–10239] Agency Information Collection Activities: Submission for OMB Review; Comment Request BILLING CODE 4163–18–P Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. mstockstill on DSK30JT082PROD with NOTICES AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to SUMMARY: VerDate Sep<11>2014 17:40 Aug 29, 2017 Jkt 241001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Number of responses per respondent Avg. burden per response (in hours) 54 37 20/60 53 52 10/60 113 1 10/60 1,800 52 10/60 1800 1 5/60 57 57 57 57 57 550 2 2 1 1 3 52 30/60 30/60 90/60 15/60 30/60 15/60 20 13 57 12 4 3 15/60 15/60 25/60 20 59 57 5 1 52 5/60 20/60 5/60 3 10 52 5 5/60 30/60 publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected; and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. E:\FR\FM\30AUN1.SGM 30AUN1

Agencies

[Federal Register Volume 82, Number 167 (Wednesday, August 30, 2017)]
[Notices]
[Pages 41267-41268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18407]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-17-0004]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    National Disease Surveillance Program II. Disease Summaries (OMB 
Control Number 0920-0004, Expires 10/31/2017)--Revision--National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    CDC requests a three-year approval for the proposed revision of the 
``National Disease Surveillance Program II. Disease Summaries'' 
information collection project.
    As with the previous approval, these data are essential for 
measuring trends in diseases, evaluating the effectiveness of current 
preventive strategies, and determining the need to modify current 
preventive measures.

[[Page 41268]]

    Diseases included in this surveillance program are Influenza Virus, 
Caliciviruses, Respiratory and Enteric Viruses, Foodborne Outbreaks, 
Waterborne Outbreaks and Enteroviruses.
    Proposed revisions include form consolidation, minor revised 
language and rewording to improve clarity and readability of the data 
collection forms and the discontinuation of multiple previously 
approved influenza collection instruments, and the National Respiratory 
& Enteric Virus Surveillance System (NREVSS) Laboratory Assessment (CDC 
55.83). CDC also requests the use of a new form, Suspect Respiratory 
Virus Patient Form, to assist health departments and clinical sites 
when they submit specimens to the CDC lab for viral pathogen 
identification. The data will enable rapid detection and 
characterization of outbreaks of known pathogens, as well as potential 
newly emerging viral pathogens.
    The frequency of response for each form will depend on the disease 
and surveillance need. This represents a 7,116 burden hour reduction 
since last approval. This reduction in burden hours is attributed 
primarily to the discontinuation of previously approved forms and 
formatting changes to existing forms. The total time burden estimate 
for all collection instruments in this revision request is 24,805.
    There are no costs to the respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of      Avg. burden
          Type of respondent                   Form name             Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Epidemiologist.......................  NORS Foodborne Disease                 54              37           20/60
                                        Transmission_Person to
                                        Person Disease
                                        Transmission_Animal
                                        Contact_Environmental
                                        Contamination_Unknown
                                        Transmission Mode_52.13.
Epidemiologist.......................  WHO COLLABORATING CENTER               53              52           10/60
                                        FOR INFLUENZA Influenza
                                        Virus Surveillance.
Epidemiologist.......................  U.S. WHO Collaborating                113               1           10/60
                                        Laboratories Influenza
                                        Testing Methods
                                        Assessment.
Epidemiologist.......................  US Outpatient Influenza-            1,800              52           10/60
                                        like Illness
                                        Surveillance Network
                                        (ILINet) Weekly_CDC
                                        55.20.
Epidemiologist.......................  US Outpatient Influenza-             1800               1            5/60
                                        like Illness
                                        Surveillance Network
                                        (ILINet) Workfolder
                                        55.20E.
Epidemiologist.......................  Influenza-Associated                   57               2           30/60
                                        Pediatric Mortality Case
                                        Report Form.
Epidemiologist.......................  Human Infection with                   57               2           30/60
                                        Novel Influenza A Virus
                                        Case Report Form.
Epidemiologist.......................  Human Infection with                   57               1           90/60
                                        Novel Influenza A Virus
                                        Severe Outcomes.
Epidemiologist.......................  Novel Influenza A Virus                57               1           15/60
                                        Case Screening Form.
Epidemiologist.......................  Antiviral Resistant                    57               3           30/60
                                        Influenza Infection Case
                                        Report Form.
Epidemiologist.......................  National Respiratory &                550              52           15/60
                                        Enteric Virus
                                        Surveillance System
                                        (NREVSS) (55.83A, B, D)
                                        (electronic).
Epidemiologist.......................  National Enterovirus                   20              12           15/60
                                        Surveillance Report:
                                        (CDC 55.9) (electronic).
Epidemiologist.......................  National Adenovirus Type               13               4           15/60
                                        Reporting System (NATRS).
Epidemiologist.......................  Middle East Respiratory                57               3           25/60
                                        Syndrome (MERS) Patient
                                        Under Investigation
                                        (PUI) Short Form.
Epidemiologist.......................  Viral Gastroenteritis                  20               5            5/60
                                        Outbreak Submission Form.
Epidemiologist.......................  NORS Waterborne Disease                59               1           20/60
                                        Transmission Form_52.12.
Epidemiologist.......................  Influenza Virus                        57              52            5/60
                                        (Electronic, Year
                                        Round), PHLIP_HL7
                                        messaging Data Elements.
Epidemiologist.......................  Influenza virus                         3              52            5/60
                                        (electronic, year round)
                                        (PHIN-MS).
Epidemiologist.......................  Suspect Respiratory Virus              10               5           30/60
                                        Patient Form.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-18407 Filed 8-29-17; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.